World’s first malaria vaccine gets WHO backing for Africa


The World Health Organisation (WHO) on Wednesday said the only approved vaccine against malaria should be widely used on African children.

It's potentially a major advance against a disease that kills hundreds of thousands of people annually.

The recommendation is for RTS,S, or Mosquirix, a vaccine developed by British drugmaker GlaxoSmithKline.

It was jointly announced in Geneva by the WHO's top advisory bodies for malaria and immunization, the Malaria Policy Advisory Group and the Strategic Advisory Group of Experts on Immunisation.

The WHO's endorsement is a crucial step for getting more investment in the production and rollout of the shot.

This recommendation is based on results from an ongoing pilot programme in Ghana, Kenya and Malawi.

More from International

Coming Up on Dubai Eye

  • The Best of Dubai Eye 103.8

    Noon - 11:00pm

    Hear the highlights from the week gone by on Dubai Eye 103.8. Listen again to the best interviews, advice and the top stories that has gripped our conversation this week.

  • Nights on Dubai Eye 103.8

    11:00pm - 6:00am

    Dubai Eye complements the conversation with the music you love from the eighties, nineties and newer.


On Dubai Eye